Alitair Pharmaceuticals is a leading pharmaceutical company based in Morristown, NJ, dedicated to developing innovative therapies to address unmet medical needs in the respiratory disease therapeutic area. They collaborate with strategic partners to develop and commercialize new therapies, focusing on key therapeutic areas such as non-narcotic prescription cough medicines, bronchiectasis treatments, and compounds for SARS-CoV-2 COVID-19 response.
With a mission to help the world breathe easier, Alitair Pharmaceuticals is committed to serving patients and providers while building value for all partner stakeholders. They leverage their unique formulation-based intellectual property and orphan drug portfolio to develop solutions that meet patient needs, aiming to improve the lives of individuals living with respiratory diseases.
Generated from the website